Physician profile
Rodney M Snow
NPI 1366454258
$457.22
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2021: $116 · 2022: $185.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $74.90 | 2019-2022 | |
| Organogenesis INC. | $72.59 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $71.64 | 2022 | |
| Bsn Medical INC | $41.41 | 2022 | |
| Hydrofera LLC | $28.88 | 2021 | |
| La Jolla Pharmaceutical Company | $26.38 | 2022 | |
| Bioventus LLC | $24.95 | 2022 | |
| Merck Sharp & Dohme LLC | $21.54 | 2021 | |
| Tactile Systems Technology INC | $21.22 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $18.14 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $16.03 | 2019 | |
| Allergan, INC. | $14.13 | 2019 | |
| Orexo US, INC. | $12.77 | 2021 | |
| Kci USA, INC. | $12.64 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Snow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.